Gaya APA

Intravenous rituximab in severe refractory primary focal segmental glomerulosclerosis. (2018). Jakarta: Faculty of Medicine, UI.

Gaya MLA

Intravenous rituximab in severe refractory primary focal segmental glomerulosclerosis. . Jakarta: Faculty of Medicine, UI, 2018. Artikel.